|
MX9504664A
(es)
*
|
1994-03-07 |
1997-05-31 |
Dow Chemical Co |
Conjugados de dendrimeros bioactivos y/o dirigidos.
|
|
BE1008134A3
(nl)
*
|
1994-03-16 |
1996-01-23 |
Dsm Nv |
Bereiding van stervormig vertakte polymeren.
|
|
GB9421282D0
(en)
*
|
1994-10-21 |
1994-12-07 |
Exxon Chemical Patents Inc |
Additives and oleaginous compositions
|
|
US5561214A
(en)
|
1995-05-18 |
1996-10-01 |
Bayer Corporation |
Hyperbranched polyaspartate esters and a process for their preparation
|
|
US5830986A
(en)
*
|
1996-10-28 |
1998-11-03 |
Massachusetts Institute Of Technology |
Methods for the synthesis of functionalizable poly(ethylene oxide) star macromolecules
|
|
US6255424B1
(en)
|
1997-11-25 |
2001-07-03 |
Colorado School Of Mines |
Dendritic polymers and convergent method of synthesis
|
|
US6660843B1
(en)
|
1998-10-23 |
2003-12-09 |
Amgen Inc. |
Modified peptides as therapeutic agents
|
|
ATE348163T1
(de)
|
1998-10-23 |
2007-01-15 |
Amgen Inc |
Thrombopoietin substitute
|
|
JP3181276B2
(ja)
|
1999-08-31 |
2001-07-03 |
科学技術振興事業団 |
樹枝状分岐構造を持つ両親媒性化合物
|
|
WO2001058987A2
(en)
|
2000-02-09 |
2001-08-16 |
Ciba Specialty Chemicals Holding Inc. |
Hyperbranched amphiphilic polymeric additives and polymer compositions with increased surface energy
|
|
DK1290013T3
(da)
|
2000-04-21 |
2006-06-26 |
Amgen Inc |
Apo-A1/All-peptidderivater
|
|
US6667300B2
(en)
|
2000-04-25 |
2003-12-23 |
Icos Corporation |
Inhibitors of human phosphatidylinositol 3-kinase delta
|
|
US6677136B2
(en)
|
2000-05-03 |
2004-01-13 |
Amgen Inc. |
Glucagon antagonists
|
|
AU2001263114A1
(en)
|
2000-05-12 |
2001-11-26 |
Amgen Inc |
Methods and compositions of matter concerning april/g70, bcma, blys/agp-3, and taci
|
|
US6407169B1
(en)
*
|
2000-12-13 |
2002-06-18 |
The University Of Waterloo |
Method for synthesis of graft polymers
|
|
JP4511075B2
(ja)
*
|
2001-04-23 |
2010-07-28 |
レンゴー株式会社 |
含硫ウレタン系デンドリマー及びその製造方法
|
|
HU229910B1
(hu)
|
2001-05-11 |
2014-12-29 |
Amgen Inc Thousand Oaks |
A TALL-1-hez kötõdõ peptidek és rokon molekulák
|
|
DK1387862T3
(en)
|
2001-05-17 |
2015-01-19 |
Basf Se |
Polymer WITH IMPROVED permanence AND OVERFLADEAFFINITET
|
|
US7332474B2
(en)
|
2001-10-11 |
2008-02-19 |
Amgen Inc. |
Peptides and related compounds having thrombopoietic activity
|
|
US7138370B2
(en)
|
2001-10-11 |
2006-11-21 |
Amgen Inc. |
Specific binding agents of human angiopoietin-2
|
|
JP3984541B2
(ja)
*
|
2001-12-26 |
2007-10-03 |
財団法人川村理化学研究所 |
星型ポリオキサゾリンからなる粒子およびその製造方法
|
|
EP1675620B1
(de)
|
2003-10-09 |
2019-05-08 |
Ambrx, Inc. |
Polymerderivate
|
|
EP1684791A4
(de)
|
2003-10-27 |
2009-07-01 |
Amgen Inc |
Zusammensetzungen und verfahren zur modulierung einer immunantwort auf ein immunogenes therapeutisches mittel
|
|
BRPI0507169A
(pt)
|
2004-02-02 |
2007-06-26 |
Ambrx Inc |
polipeptìdeos do hormÈnio de crescimento humano modificados e seu usos
|
|
LT2612862T
(lt)
|
2004-05-13 |
2017-01-25 |
Icos Corporation |
Chinazolinonai kaip žmogaus fosfatidilinozitol-3-kinazės delta inhibitoriai
|
|
EP1771205B1
(de)
|
2004-06-18 |
2016-10-26 |
Ambrx, Inc. |
Neuartige antigen-bindende polypeptide und ihre verwendungen
|
|
EP1773400A2
(de)
|
2004-07-08 |
2007-04-18 |
Amgen Inc. |
Therapeutische peptide
|
|
JP2008507280A
(ja)
|
2004-07-21 |
2008-03-13 |
アンブレツクス・インコーポレイテツド |
非天然コードアミノ酸を用いた生合成ポリペプチド
|
|
JP4421614B2
(ja)
*
|
2004-08-13 |
2010-02-24 |
日本曹達株式会社 |
スターポリマー、酸分解性樹脂組成物、レジスト組成物およびジ(メタ)アクリレート化合物
|
|
JP2008525032A
(ja)
|
2004-12-22 |
2008-07-17 |
アンブレツクス・インコーポレイテツド |
組換えヒト成長ホルモンを発現及び精製するための方法
|
|
NZ555308A
(en)
|
2004-12-22 |
2010-10-29 |
Ambrx Inc |
Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
|
|
BRPI0519170A8
(pt)
|
2004-12-22 |
2018-05-08 |
Ambrx Inc |
formulações de hormônio de crescimento humano que compreendem um aminoácido não naturalmente codificado
|
|
JP4990792B2
(ja)
|
2004-12-22 |
2012-08-01 |
アンブレツクス・インコーポレイテツド |
アミノアシル−tRNAシンテターゼの組成物およびこの使用
|
|
CA2594557C
(en)
|
2004-12-22 |
2016-04-26 |
Ambrx, Inc. |
Modified human growth hormone
|
|
US9487631B2
(en)
|
2005-05-21 |
2016-11-08 |
University Of Durham |
Surface active polymeric systems
|
|
KR20080026135A
(ko)
|
2005-06-03 |
2008-03-24 |
암브룩스, 인코포레이티드 |
개선된 인간 인터페론 분자 및 이의 용도
|
|
WO2006138145A1
(en)
|
2005-06-14 |
2006-12-28 |
Northwestern University |
Nucleic acid functionalized nanoparticles for therapeutic applications
|
|
WO2007021297A1
(en)
|
2005-08-18 |
2007-02-22 |
Ambrx, Inc. |
COMPOSITIONS OF tRNA AND USES THEREOF
|
|
KR20080074120A
(ko)
|
2005-10-13 |
2008-08-12 |
휴먼 게놈 사이언시즈, 인코포레이티드 |
자가항체 양성 질환 환자의 치료에 유용한 방법 및 조성물
|
|
HUE031341T2
(hu)
|
2005-10-25 |
2017-07-28 |
Starpharma Pty Ltd |
Ellenõrzött sztöchiometriájú makromolekuláris vegyületek
|
|
AR056806A1
(es)
|
2005-11-14 |
2007-10-24 |
Amgen Inc |
Moleculas quimericas de anticuerpo rankl- pth/ pthrp
|
|
EP1951890A4
(de)
|
2005-11-16 |
2009-06-24 |
Ambrx Inc |
Verfahren und zusammensetzungen mit nichtnatürlichen aminosäuren
|
|
WO2007102946A2
(en)
|
2006-01-23 |
2007-09-13 |
Amgen Inc. |
Crystalline polypeptides
|
|
DE602007009954D1
(de)
|
2006-03-22 |
2010-12-02 |
Viral Logic Systems Technology |
Verfahren zur identifizierung von polypeptid-targets
|
|
US8129334B2
(en)
|
2006-03-31 |
2012-03-06 |
The Regents Of The University Of California |
Methods and compositions for treating neurodegenerative disorders and Alzheimer'S disease and improving normal memory
|
|
US8377448B2
(en)
|
2006-05-15 |
2013-02-19 |
The Board Of Trustees Of The Leland Standford Junior University |
CD47 related compositions and methods for treating immunological diseases and disorders
|
|
US7981425B2
(en)
|
2006-06-19 |
2011-07-19 |
Amgen Inc. |
Thrombopoietic compounds
|
|
CA2787343C
(en)
|
2006-06-26 |
2016-08-02 |
Amgen Inc. |
Compositions comprising modified lcat and uses thereof
|
|
US20080020043A1
(en)
*
|
2006-07-20 |
2008-01-24 |
Marc Gingras |
Dendrimer-Drug Conjugates
|
|
CN101511856B
(zh)
|
2006-09-08 |
2016-01-20 |
Ambrx公司 |
脊椎动物细胞中抑制因子trna的转录
|
|
AU2007292892B9
(en)
|
2006-09-08 |
2013-02-28 |
Ambrx, Inc. |
Hybrid suppressor tRNA for vertebrate cells
|
|
KR20090060294A
(ko)
|
2006-09-08 |
2009-06-11 |
암브룩스, 인코포레이티드 |
변형된 인간 혈장 폴리펩티드 또는 Fc 스캐폴드 및 그의 용도
|
|
EP2441768A1
(de)
|
2006-11-13 |
2012-04-18 |
Eli Lilly & Co. |
Thienopyrimidinone zur Behandlung von Entzündungserkrankungen und Karzinomen
|
|
AU2008212820B2
(en)
|
2007-02-09 |
2014-01-30 |
Northwestern University |
Particles for detecting intracellular targets
|
|
JP5288363B2
(ja)
*
|
2007-02-16 |
2013-09-11 |
国立大学法人九州大学 |
デンドロンとメソゲンとを有する化合物、液晶組成物及び光素子
|
|
CA2682147C
(en)
|
2007-03-30 |
2017-08-08 |
Ambrx, Inc. |
Modified fgf-21 polypeptides and their uses
|
|
CN101675071B
(zh)
|
2007-05-02 |
2014-06-18 |
Ambrx公司 |
经修饰干扰素β多肽和其用途
|
|
EP2826863B1
(de)
|
2007-05-30 |
2017-08-23 |
Northwestern University |
Nukleinsäurefunktionalisierte Nanopartikel für therapeutische Anwendungen
|
|
SI2489731T1
(sl)
|
2007-07-26 |
2014-12-31 |
Amgen Inc. Patent Operations, M/S 28-2-C |
Modificirani encimi lecitin-holesterol aciltransferaze
|
|
CA2703830A1
(en)
|
2007-11-20 |
2009-05-28 |
Ambrx, Inc. |
Modified insulin polypeptides and their uses
|
|
SG188143A1
(en)
|
2008-02-08 |
2013-03-28 |
Ambrx Inc |
Modified leptin polypeptides and their uses
|
|
WO2009158432A2
(en)
|
2008-06-27 |
2009-12-30 |
Amgen Inc. |
Ang-2 inhibition to treat multiple sclerosis
|
|
WO2010002895A2
(en)
|
2008-06-30 |
2010-01-07 |
The Regents Of The University Of Michigan |
Lysosomal phospholipase a2 (lpla2) activity as a diagnostic and therapeutic target for identifying and treating systemic lupus erythematosis
|
|
EP2318029B1
(de)
|
2008-07-23 |
2017-11-01 |
Ambrx, Inc. |
Modifizierte bovine g-csf-polypeptide und ihre verwendung
|
|
US8278418B2
(en)
|
2008-09-26 |
2012-10-02 |
Ambrx, Inc. |
Modified animal erythropoietin polypeptides and their uses
|
|
PE20110480A1
(es)
|
2008-09-26 |
2011-07-01 |
Ambrx Inc |
Microorganismos y vacunas dependientes de replicacion de aminoacidos no naturales
|
|
US9815712B2
(en)
|
2008-10-03 |
2017-11-14 |
California Institute Of Technology |
High capacity perchlorate-selective resins from hyperbranched macromolecules
|
|
WO2010040117A2
(en)
*
|
2008-10-03 |
2010-04-08 |
California Institute Of Technology |
Extraction of anions from solutions and mixtures using hyperbranched macromolecules
|
|
KR20170060179A
(ko)
|
2008-11-13 |
2017-05-31 |
길리아드 칼리스토가 엘엘씨 |
혈액 종양에 대한 요법
|
|
US9492449B2
(en)
|
2008-11-13 |
2016-11-15 |
Gilead Calistoga Llc |
Therapies for hematologic malignancies
|
|
AU2009316286B2
(en)
|
2008-11-24 |
2016-05-26 |
Northwestern University |
Polyvalent RNA-nanoparticle compositions
|
|
US20100233270A1
(en)
|
2009-01-08 |
2010-09-16 |
Northwestern University |
Delivery of Oligonucleotide-Functionalized Nanoparticles
|
|
AU2010229968A1
(en)
|
2009-03-24 |
2011-10-13 |
Gilead Calistoga Llc |
Atropisomers of2-purinyl-3-tolyl-quinazolinone derivatives and methods of use
|
|
JP2012524126A
(ja)
|
2009-04-20 |
2012-10-11 |
ギリアド カリストガ リミテッド ライアビリティ カンパニー |
固形腫瘍の治療方法
|
|
CN102647998A
(zh)
|
2009-06-19 |
2012-08-22 |
医学免疫有限责任公司 |
蛋白酶变体
|
|
WO2011001657A1
(ja)
*
|
2009-07-01 |
2011-01-06 |
独立行政法人科学技術振興機構 |
ポリイオンデンドリマー、及びそれよりなるハイドロゲル
|
|
CA2768843A1
(en)
|
2009-07-21 |
2011-01-27 |
Gilead Calistoga Llc |
Treatment of liver disorders with pi3k inhibitors
|
|
WO2011038139A1
(en)
|
2009-09-23 |
2011-03-31 |
Amgen Inc. |
Treatment of ovarian cancer using a specific binding agent of human angiopoietin-2 in combination with a taxane
|
|
WO2011049625A1
(en)
|
2009-10-20 |
2011-04-28 |
Mansour Samadpour |
Method for aflatoxin screening of products
|
|
CN102666879B
(zh)
|
2009-10-30 |
2016-02-24 |
西北大学 |
模板化的纳米缀合物
|
|
LT2496567T
(lt)
|
2009-11-05 |
2017-11-27 |
Rhizen Pharmaceuticals S.A. |
Nauji benzopirano kinazės moduliatoriai
|
|
US8658702B2
(en)
|
2009-12-17 |
2014-02-25 |
Mamadou Diallo |
Soluble anion exchangers from hyperbranched macromolecules
|
|
JP2013515081A
(ja)
|
2009-12-21 |
2013-05-02 |
アンブルックス,インコーポレイテッド |
修飾されているブタのソマトトロピンポリペプチドおよびそれらの使用
|
|
EA201290541A1
(ru)
|
2009-12-21 |
2013-05-30 |
Амбркс, Инк. |
Модифицированные бычьи соматотропиновые полипептиды и их применение
|
|
KR20120128631A
(ko)
*
|
2010-01-20 |
2012-11-27 |
바스프 에스이 |
수성 중합체 분산액의 제조 방법
|
|
EP2569336A1
(de)
|
2010-05-14 |
2013-03-20 |
Amgen Inc. |
Verbesserte todesrezeptoragonisten
|
|
JP5960688B2
(ja)
|
2010-05-17 |
2016-08-02 |
インコゼン セラピューティクス プライベート リミテッド |
プロテインキナーゼ調節物質としての新規3,5−二置換−3h−[1,2,3]トリアゾロ[4,5−b]ピリジン化合物
|
|
PE20140160A1
(es)
|
2010-08-17 |
2014-02-08 |
Ambrx Inc |
Polipeptidos de relaxina modificados y sus usos
|
|
US9567386B2
(en)
|
2010-08-17 |
2017-02-14 |
Ambrx, Inc. |
Therapeutic uses of modified relaxin polypeptides
|
|
TWI480288B
(zh)
|
2010-09-23 |
2015-04-11 |
Lilly Co Eli |
牛顆粒細胞群落刺激因子及其變體之調配物
|
|
PT2705029T
(pt)
|
2011-05-04 |
2019-02-01 |
Rhizen Pharmaceuticals S A |
Novos compostos como moduladores de proteína quinases
|
|
CN104023749B
(zh)
|
2011-09-14 |
2019-12-17 |
西北大学 |
能穿过血脑屏障的纳米缀合物
|
|
ES2848273T3
(es)
|
2012-03-05 |
2021-08-06 |
Gilead Calistoga Llc |
Formas polimórficas de (S)-2-(1-(9H-purin-6-ilamino)propilo)-5-fluoro-3-fenilquinazolina-4(3H)-ona
|
|
US9382387B2
(en)
|
2012-03-13 |
2016-07-05 |
California Institute Of Technology |
Rapid self-assembly of block copolymers to photonic crystals
|
|
WO2013138494A1
(en)
|
2012-03-13 |
2013-09-19 |
California Institute Of Technology |
Periodic nanostructures from self assembled wedge-type block-copolymers
|
|
WO2013148877A1
(en)
|
2012-03-28 |
2013-10-03 |
Amgen Inc. |
Dr5 receptor agonist combinations
|
|
CN104321322A
(zh)
|
2012-03-30 |
2015-01-28 |
理森制药股份公司 |
作为c-met蛋白激酶调节剂的新型3,5-二取代-3h-咪唑并[4,5-b]吡啶和3,5-二取代-3h-[1,2,3]三唑并[4,5-b]吡啶化合物
|
|
US9738724B2
(en)
|
2012-06-08 |
2017-08-22 |
Sutro Biopharma, Inc. |
Antibodies comprising site-specific non-natural amino acid residues, methods of their preparation and methods of their use
|
|
EP3135690A1
(de)
|
2012-06-26 |
2017-03-01 |
Sutro Biopharma, Inc. |
Modifizierte fc-proteine mit stellenspezifischen nichtnatürlichen aminosäureresten, konjugate daraus, verfahren zu deren herstellung und verfahren zu deren verwendung
|
|
PT2877490T
(pt)
|
2012-06-27 |
2019-02-12 |
Univ Princeton |
Inteínas clivadas, conjugados e suas utilizações
|
|
US9453943B2
(en)
|
2012-06-28 |
2016-09-27 |
California Institute Of Technology |
Photonic structures from self assembly of brush block copolymers and polymer blends
|
|
SI2890402T1
(sl)
|
2012-08-31 |
2019-07-31 |
Sutro Biopharma, Inc. |
Modificirane aminokisline vsebujoče acido skupino
|
|
US9272075B2
(en)
|
2013-02-04 |
2016-03-01 |
W.L. Gore & Associates, Inc. |
Coating for substrate
|
|
RU2698315C2
(ru)
|
2013-02-04 |
2019-08-26 |
В.Л. Гор Энд Ассошиейтс, Инк. |
Покрытие для подложки
|
|
WO2015006555A2
(en)
|
2013-07-10 |
2015-01-15 |
Sutro Biopharma, Inc. |
Antibodies comprising multiple site-specific non-natural amino acid residues, methods of their preparation and methods of their use
|
|
WO2015054658A1
(en)
|
2013-10-11 |
2015-04-16 |
Sutro Biopharma, Inc. |
Modified amino acids comprising tetrazine functional groups, methods of preparation, and methods of their use
|
|
JP6255210B2
(ja)
*
|
2013-10-24 |
2017-12-27 |
アーゼッド・エレクトロニック・マテリアルズ(ルクセンブルグ)ソシエテ・ア・レスポンサビリテ・リミテ |
レジスト下層膜形成組成物
|
|
JP2017500319A
(ja)
|
2013-12-20 |
2017-01-05 |
ギリアード カリストガ エルエルシー |
(s)−2−(1−(9h−プリン−6−イルアミノ)プロピル)−5−フルオロ−3−フェニルキナゾリン−4(3h)−オンの塩酸塩の多形形態
|
|
EP3083630B1
(de)
|
2013-12-20 |
2019-08-21 |
Gilead Calistoga LLC |
Prozessverfahren für phosphatidylinositol-3-kinase-hemmer
|
|
US11021467B2
(en)
|
2014-06-13 |
2021-06-01 |
Gilead Sciences, Inc. |
Phosphatidylinositol 3-kinase inhibitors
|
|
MX2017004947A
(es)
|
2014-10-24 |
2017-06-29 |
Bristol Myers Squibb Co |
Polipeptidos del factor de crecimiento de fibroblastos 2 (fgf-21) modificados y usos de los mismos.
|
|
KR102526632B1
(ko)
|
2014-11-19 |
2023-04-27 |
엔제트피 유케이 리미티드 |
스테로이드 FXR 조절인자를 제조하기 위한 중간체로서의 5β-6-알킬-7-하이드록시-3-온 스테로이드
|
|
ES2748692T3
(es)
|
2014-11-19 |
2020-03-17 |
Nzp Uk Ltd |
Esteroides 6.alfa.-alquil-3,7-diona como intermedios para la producción de moduladores FXR de esteroides
|
|
EA033427B1
(ru)
|
2014-11-19 |
2019-10-31 |
Nzp Uk Ltd |
6-алкил-7-гидрокси-4-ен-3-оновые стероиды в качестве промежуточных соединений для получения стероидных модуляторов fxr
|
|
JP6698085B2
(ja)
|
2014-11-19 |
2020-05-27 |
エヌゼットピー ユーケー リミテッド |
ステロイドFXRモジュレーター製造のための中間体としての6α−アルキル−6,7−ジオン−ステロイド
|
|
WO2016081911A2
(en)
|
2014-11-21 |
2016-05-26 |
Northwestern University |
The sequence-specific cellular uptake of spherical nucleic acid nanoparticle conjugates
|
|
US10608280B2
(en)
|
2015-03-09 |
2020-03-31 |
California Institute Of Technology |
Brush block copolymer electrolytes and electrocatalyst compositions
|
|
WO2017096262A1
(en)
|
2015-12-04 |
2017-06-08 |
Jomoco, Corp. |
Compositions and methods to mitigate or prevent an immune response to an immunogenic therapeutic molecule in non-human primates
|
|
AU2017212739B2
(en)
|
2016-01-27 |
2024-03-21 |
Sutro Biopharma, Inc. |
Anti-CD74 antibody conjugates, compositions comprising anti-CD74 antibody conjugates and methods of using anti-CD74 antibody conjugates
|
|
GB201608776D0
(en)
|
2016-05-18 |
2016-06-29 |
Dextra Lab Ltd |
Methods and compounds
|
|
GB201608777D0
(en)
|
2016-05-18 |
2016-06-29 |
Dextra Lab Ltd |
Compounds
|
|
SG10201912034UA
(en)
|
2017-02-08 |
2020-02-27 |
Bristol Myers Squibb Co |
Modified relaxin polypeptides comprising a pharmacokinetic enhancer and uses thereof
|
|
EP3585411B1
(de)
|
2017-02-21 |
2025-05-28 |
The Regents Of The University Of Michigan |
Il-22bp-zusammensetzungen und verfahren zur behandlung von krankheiten damit
|
|
JP6844773B2
(ja)
*
|
2017-03-01 |
2021-03-17 |
国立大学法人 岡山大学 |
細胞内導入機能を有するホウ素を含むデンドリマー
|
|
US11053356B2
(en)
|
2017-03-07 |
2021-07-06 |
California Institute Of Technology |
Control of polymer architectures by living ring-opening metathesis copolymerization
|
|
EP3658588A1
(de)
|
2017-07-26 |
2020-06-03 |
Sutro Biopharma, Inc. |
Verfahren zur verwendung von anti-cd74-antikörpern und antikörperkonjugaten bei der behandlung von t-zell-lymphomen
|
|
MA50265A
(fr)
|
2017-09-18 |
2020-07-29 |
Sutro Biopharma Inc |
Conjugués anticorps-récepteur alpha anti-folate et leurs utilisations
|
|
KR20210057124A
(ko)
|
2018-09-11 |
2021-05-20 |
암브룩스, 인코포레이티드 |
인터류킨-2 폴리펩타이드 접합체 및 그의 용도
|
|
JP2022500454A
(ja)
|
2018-09-17 |
2022-01-04 |
ストロ バイオファーマ インコーポレーテッド |
抗葉酸受容体抗体コンジュゲートによる併用療法
|
|
JP2022512746A
(ja)
|
2018-10-19 |
2022-02-07 |
アンブルックス,インコーポレイテッド |
インターロイキン-10ポリペプチド複合体、その二量体、およびそれらの使用
|
|
JP7689075B2
(ja)
|
2019-01-30 |
2025-06-05 |
コロラド・ステート・ユニバーシティ・リサーチ・ファウンデーション |
ポリマー複合フォトニック結晶コーティング
|
|
WO2020160299A1
(en)
|
2019-02-01 |
2020-08-06 |
Colorado State University Research Foundation |
Multi-coat polymer photonic crystal films
|
|
CN119455003A
(zh)
|
2019-02-12 |
2025-02-18 |
Ambrx公司 |
包含抗体-tlr激动剂缀合物的组合物、方法和用途
|
|
US20220362394A1
(en)
|
2019-05-03 |
2022-11-17 |
Sutro Biopharma, Inc. |
Anti-bcma antibody conjugates
|
|
EP3980423A1
(de)
|
2019-06-10 |
2022-04-13 |
Sutro Biopharma, Inc. |
5h-pyrrolo[3,2-d]pyrimidin-2,4-diaminverbindungen und ihre antikörper-konjugate
|
|
EP3983410A1
(de)
|
2019-06-17 |
2022-04-20 |
Sutro Biopharma, Inc. |
1-(4-(aminomethyl)benzyl)-2-butyl-2h-pyrazolo[3,4-c]quinolin-4-aminderivate und verwandte verbindungen als toll-like- rezeptor (tlr) 7/8-agonisten sowie antikörper-wirkstoff-konjugate davon zur verwendung in der krebstherapie und -diagnose
|
|
US20230095053A1
(en)
|
2020-03-03 |
2023-03-30 |
Sutro Biopharma, Inc. |
Antibodies comprising site-specific glutamine tags, methods of their preparation and methods of their use
|
|
EP4117732A1
(de)
|
2020-03-11 |
2023-01-18 |
Ambrx, Inc. |
Interleukin-2-polypeptidkonjugate und verfahren zur verwendung davon
|
|
WO2022040596A1
(en)
|
2020-08-20 |
2022-02-24 |
Ambrx, Inc. |
Antibody-tlr agonist conjugates, methods and uses thereof
|
|
WO2022103983A2
(en)
|
2020-11-11 |
2022-05-19 |
Sutro Biopharma, Inc. |
Fluorenylmethyloxycarbonyl and fluorenylmethylaminocarbonyl compounds, protein conjugates thereof, and methods for their use
|
|
WO2022212899A1
(en)
|
2021-04-03 |
2022-10-06 |
Ambrx, Inc. |
Anti-her2 antibody-drug conjugates and uses thereof
|
|
CN117396231A
(zh)
|
2021-04-30 |
2024-01-12 |
新基公司 |
使用抗BCMA抗体药物缀合物(ADC)与γ分泌酶抑制剂(GSI)的组合的组合疗法
|
|
EP4543494A1
(de)
|
2022-06-27 |
2025-04-30 |
Sutro Biopharma, Inc. |
Beta-glucuronid-linker-payloads, proteinkonjugate davon und verfahren dafür
|
|
IL317782A
(en)
|
2022-06-30 |
2025-02-01 |
Sutro Biopharma Inc |
Anti-ROR1 antibodies and conjugates thereof, compositions containing anti-ROR1 antibodies or conjugates thereof, and methods for preparing and using anti-ROR1 antibodies and conjugates thereof
|
|
CN119948030A
(zh)
|
2022-07-15 |
2025-05-06 |
苏特罗生物制药公司 |
蛋白酶/酶可切割连接体-有效载荷及蛋白质偶联物
|
|
WO2024044780A1
(en)
|
2022-08-26 |
2024-02-29 |
Sutro Biopharma, Inc. |
Interleukin-18 variants and uses thereof
|
|
WO2024098023A2
(en)
|
2022-11-04 |
2024-05-10 |
Sutro Biopharma, Inc. |
Interferon alpha polypeptides and conjugates
|
|
AU2024315750A1
(en)
|
2023-07-31 |
2026-03-05 |
Sutro Biopharma, Inc. |
Sting agonist compounds and conjugates
|
|
WO2025037108A2
(en)
|
2023-08-15 |
2025-02-20 |
Board Of Trustees Of The Leland Stanford Junior University |
Modified thrombopoietin
|
|
EP4791439A1
(de)
|
2023-10-13 |
2026-08-19 |
Sutro Biopharma, Inc. |
Antikörper-wirkstoff-konjugate mit doppelter nutzlast
|
|
US12540197B2
(en)
|
2023-10-13 |
2026-02-03 |
Sutro Biopharma, Inc. |
Anti-tissue factor antibodies and antibody conjugates, compositions comprising anti-tissue factor antibodies or antibody conjugates, and methods of making and using anti-tissue factor antibodies and antibody conjugates
|
|
WO2025264647A1
(en)
|
2024-06-18 |
2025-12-26 |
Sutro Biopharma, Inc. |
Oxoadenine tlr7 agonist compounds and conjugates
|
|
WO2026043823A2
(en)
|
2024-08-19 |
2026-02-26 |
Sutro Biopharma, Inc. |
Antibodies comprising site-specific non-natural amino acid residues, methods of preparation and uses thereof
|
|
WO2026080697A1
(en)
|
2024-10-09 |
2026-04-16 |
Sutro Biopharma, Inc. |
Antibody conjugates with high payload to antibody ratios, compositions comprising the same, and methods of their use
|
|
WO2026080688A1
(en)
|
2024-10-09 |
2026-04-16 |
Sutro Biopharma, Inc. |
Dual mechanism of action payload antibody drug conjugates
|
|
WO2026080692A1
(en)
|
2024-10-09 |
2026-04-16 |
Sutro Biopharma, Inc. |
Branched beta-glucuronide linker-payloads, protein conjugates thereof, and methods thereof
|